These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 21593228

  • 1. Risk of venous thromboembolism with drospirenone-containing oral contraceptives.
    Brown DA, Vartan CM.
    Am J Health Syst Pharm; 2011 Jun 01; 68(11):1003-10. PubMed ID: 21593228
    [Abstract] [Full Text] [Related]

  • 2. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
    Sehovic N, Smith KP.
    Ann Pharmacother; 2010 May 01; 44(5):898-903. PubMed ID: 20371756
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives.
    Dinger J, Bardenheuer K, Heinemann K.
    Contraception; 2014 Apr 01; 89(4):253-63. PubMed ID: 24576793
    [Abstract] [Full Text] [Related]

  • 4. Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters.
    Larivée N, Suissa S, Coulombe J, Tagalakis V, Filion KB.
    Drug Saf; 2017 Jul 01; 40(7):583-596. PubMed ID: 28382493
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives.
    Dinger J, Möhner S, Heinemann K.
    Contraception; 2016 May 01; 93(5):378-85. PubMed ID: 26825258
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
    Contracept Rep; 1996 Apr 01; 7(1):3-6. PubMed ID: 12320047
    [Abstract] [Full Text] [Related]

  • 12. Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studies.
    Shapiro S, Dinger J.
    J Fam Plann Reprod Health Care; 2010 Jan 01; 36(1):33-8. PubMed ID: 20067670
    [Abstract] [Full Text] [Related]

  • 13. Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database.
    Parkin L, Sharples K, Hernandez RK, Jick SS.
    BMJ; 2011 Apr 21; 342():d2139. PubMed ID: 21511804
    [Abstract] [Full Text] [Related]

  • 14. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
    Dinger J, Assmann A, Möhner S, Minh TD.
    J Fam Plann Reprod Health Care; 2010 Jul 21; 36(3):123-9. PubMed ID: 20659364
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review.
    Wu CQ, Grandi SM, Filion KB, Abenhaim HA, Joseph L, Eisenberg MJ.
    BJOG; 2013 Jun 21; 120(7):801-10. PubMed ID: 23530659
    [Abstract] [Full Text] [Related]

  • 17. Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?
    Bird ST, Delaney JA, Etminan M, Brophy JM, Hartzema AG.
    J Thromb Haemost; 2013 Jun 21; 11(6):1059-68. PubMed ID: 23574590
    [Abstract] [Full Text] [Related]

  • 18. Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation "pill scare".
    Heinemann LA, Dinger JC, Assmann A, Minh TD.
    Contraception; 2010 May 21; 81(5):401-7. PubMed ID: 20399946
    [Abstract] [Full Text] [Related]

  • 19. [Oral contraceptive pill and thrombotic risk: epidemiological studies].
    Fruzzetti F, Perini D, Spirito N, Manca R.
    Minerva Ginecol; 2012 Dec 21; 64(6):539-49. PubMed ID: 23232538
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.